CI

At a glance

ClinicalIndex Comparison Record
Phase 2Active· 88 enrolled
Drug / intervention
Radiationradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02917421
NCT02917421Phase 2Active

Accelerated Radiation Therapy (ART) To The Breast And Nodal Stations After Neo-Adjuvant Systemic Therapy And Surgery: A Feasibility Study

Weill Medical College of Cornell University·interventional·Posted Sep 28, 2016·Updated Apr 17, 2026

In Brief

A Phase 2 clinical trial evaluating Radiation for Breast Cancer. Active but no longer recruiting, targeting 88 participants across 3 sites.

Detailed Summary

This protocol is for patients with newly diagnosed breast cancer with an indication for post-operative radiotherapy after neo-adjuvant chemotherapy and surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2Active
20172018201920202021202220232024202520262027
First PostedSep 28, 2016
Enrollment StartDec 19, 2016
Primary CompletionMay 19, 2023
Study CompletionDec 31, 2026
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 9.8 years ago

Interventions

Radiationradiation

(Post-segmental Mastectomy, post-mastectomy and Post-mastectomy with expanders or final reconstruction): Prone whole breast or chest wall 3D-CRT or IMRT at 2.7 Gy X 15 fractions (40.50 Gy) with a concomitant boost of 0.50 Gy (7.5 Gy) to the original tumor bed in post-segmental mastectomy patients or mastectomy scar in post-mastectomy patients. Patients who have undergone reconstruction will not receive concomitant boost.